From European Huntington Association:
Join us for an open webinar with Novartis to get the latest updates on the INVEST-HD trial, including timeline updates and insights from a clinical perspective.
Featuring presentations by Beth Borowsky, Senior Global Programme Clinical Head in Neuroscience at Novartis, and Åsa Petersén, MD PhD from Lund University, followed by a Q&A moderated by Astri Arnesen.
📅 June 2nd
🕕 6:00PM CET
